Education
About Us
Working with TipRanks
Follow Us
PharmaNutra SpA (IT:PHN)
:PHN
PHN Stock Chart & Stats
€67.00
-€0.80(-1.51%)
At close: 4:00 PM EST
€67.00
-€0.80(-1.51%)
Day’s Range― - ―
52-Week Range€38.75 - €68.10
Previous CloseN/A
Volume2.81K
Average Volume (3M)25.97K
Market Cap
€648.63M
Enterprise Value€634.42M
Total Cash (Recent Filing)€21.96M
Total Debt (Recent Filing)€20.98M
Price to Earnings (P/E)36.9
Beta0.49
Next Earnings
Mar 17, 2026EPS Estimate
0.62Next Dividend Ex-DateN/A
Dividend Yield1.86%
Share Statistics
EPS (TTM)0.50
Shares Outstanding9,680,977
10 Day Avg. Volume12,507
30 Day Avg. Volume25,966
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)8.41
Price to Sales (P/S)4.50
P/FCF Ratio32.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€81.00Price Target Upside20.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)2.47
Revenue Forecast (FY)€151.41M
Bulls Say, Bears Say
Bulls Say
Product And Brand StrengthStrong uptake of recent product launches, with SiderAL described as a top performer despite premium pricing, supports brand reinforcement and broader customer adoption.
Retail Commercial TractionAmazon-ranking gains for SiderAL and a higher buyer-count label signal rising consumer demand and improved e-commerce market position.
U.S. Commercial ExpansionRevised PHN USA commercial plan and a shift toward a direct retail-pharmacy model indicate potential acceleration of U.S. sales and improved route-to-market execution.
Bears Say
Margin Pressure And Cash FlowOngoing investments in new ventures may compress margins and increase working capital needs, which could constrain free cash flow.
PharmaNutra SpA News
PHN FAQ
What was PharmaNutra SpA’s price range in the past 12 months?
PharmaNutra SpA lowest stock price was €38.75 and its highest was €68.10 in the past 12 months.
What is PharmaNutra SpA’s market cap?
PharmaNutra SpA’s market cap is €648.63M.
When is PharmaNutra SpA’s upcoming earnings report date?
PharmaNutra SpA’s upcoming earnings report date is Mar 17, 2026 which is in 14 days.
How were PharmaNutra SpA’s earnings last quarter?
PharmaNutra SpA released its earnings results on Nov 10, 2025. The company reported €0.5 earnings per share for the quarter, beating the consensus estimate of N/A by €0.5.
Is PharmaNutra SpA overvalued?
According to Wall Street analysts PharmaNutra SpA’s price is currently Undervalued.
Does PharmaNutra SpA pay dividends?
PharmaNutra SpA pays a Annually dividend of €1 which represents an annual dividend yield of 1.86%. See more information on PharmaNutra SpA dividends here
What is PharmaNutra SpA’s EPS estimate?
PharmaNutra SpA’s EPS estimate is 0.62.
How many shares outstanding does PharmaNutra SpA have?
PharmaNutra SpA has 9,680,977 shares outstanding.
What happened to PharmaNutra SpA’s price movement after its last earnings report?
PharmaNutra SpA reported an EPS of €0.5 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.563%.
Which hedge fund is a major shareholder of PharmaNutra SpA?
Currently, no hedge funds are holding shares in IT:PHN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PharmaNutra SpA
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
PHN Stock 12 Month Forecast
Average Price Target
€81.00
▲(20.90% Upside)
Technical Analysis
Philogen SpA
―
Farmacosmo S.P.A.
―
Farmae SpA
―
Laboratorio Farmaceutico Erfo SpA
―
Svas Biosana S.p.A.
―
Options Prices
Currently, No data available
---